Clinical Report: The Impact of Oncogenic Viruses on Squamous Cell Carcinoma

Overview

This comprehensive review highlights the significant role of oncogenic viruses, particularly HPV, in the etiology and prognosis of oral cavity and oropharyngeal squamous cell carcinoma (SCC). The findings indicate a strong association between HPV infection and oropharyngeal SCC, while the role of other oncogenic viruses remains less clear.

Background

Oral cavity and oropharyngeal SCC are major contributors to head and neck malignancies, characterized by high morbidity and mortality. Understanding the impact of oncogenic viruses, especially HPV, is crucial as it influences disease incidence, prognosis, and treatment strategies. The differentiation between HPV-positive and HPV-negative SCC is essential for accurate staging and management.

Data Highlights

No numerical data provided in the source material.

Key Findings

• HPV-positive oropharyngeal SCC is associated with improved survival compared to HPV-negative cases.
• HPV status is now a key determinant in contemporary staging systems for oropharyngeal SCC.
• Methodological variability in viral detection approaches complicates the assessment of oncogenic virus contributions.
• Evidence supporting a causal role for non-HPV oncogenic viruses in SCC remains limited and heterogeneous.
• HPV16 is the predominant genotype found in oropharyngeal SCC.

Clinical Implications

The findings emphasize the need for standardized assessment frameworks for viral detection in SCC. Clinicians should consider HPV status in the management and prognostication of oropharyngeal SCC.

Conclusion

The review underscores the importance of oncogenic viruses in the development of oral cavity and oropharyngeal SCC, particularly HPV, while highlighting the need for further research into the roles of other viruses.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- HPV-specific innovations and controversies in therapeutic strategies for HPV-associated oropharyngeal carcinoma
2. Frontiers in Immunology, 2026 -- The microbiome-inflammation-immune axis in oral squamous cell carcinoma: from mechanistic insights to therapeutic perspectives
3. The ASCO Post, 2019 -- Oral HPV DNA Persistence and Disease Progression in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
4. The ASCO Post, 2016 -- Characteristics of HPV-Driven Nonoropharyngeal Squamous Cell Carcinomas of the Head and Neck
5. hpv head and neck guideline update, 2025 -- HPV Head and Neck Update Summary Recommendations
6. Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis - PubMed
7. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial - PubMed
8. hpv head and neck guideline update
9. Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis - PubMed
10. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial - PubMed